Vapotherm

Last updated
Vapotherm, Inc.
Company type Public
OTCQX:  VAPO (since 2023)
NYSE: VAPO
Industry Medical devices
FoundedJanuary 1, 1999 (1999-01-01) in Stevensville, MD, U.S.
FoundersBill Niland
Jun Cortez
Headquarters Exeter, New Hampshire, U.S
Area served
Worldwide
Brands
  • Precision Flow®
  • Precision Flow Heliox®
  • Flowrest®
Number of employees
116 (2015)
Website vapotherm.com OOjs UI icon edit-ltr-progressive.svg

Vapotherm Inc. is a publicly held corporation based in Exeter, New Hampshire that was founded in 1999 as a medical device manufacturer after creating the first heated and humidified high flow therapy nasal cannula system.

Contents

Vapotherm Precision Flow

In 2009, Vapotherm released a new flagship product replacing the Vapotherm 2000i (that had been recalled in 2005, and then re-approved for use in the market in 2006); boasting a completely integrated electronic flow meter and electronic blender, as well as an internal oxygen analyzer. The Precision Flow is currently Vapotherm's flagship capital unit and is the premier medical device for providing high flow therapy.

Precision Flow Heliox

Through an agreement with Praxair, Vapotherm provides a Precision Flow model specially calibrated specifically for 80:20 heliox gas for use in patients who may benefit from heliox therapy.

Vapotherm Q50 Compressor

In November 2015 Vapotherm announced its own model of medical air compressor, specifically to be used with their flagship Precision Flow device.

Vapotherm 2000i

Recall controversy

In 2005, contaminated Vapotherm 2000i respiratory gas humidification devices were associated with an outbreak of Ralstonia mannitolilytica bacteria in children in the United States. [1] Vapotherm issued a recall of all 2000i devices on 13 October 2005. [2] Vapotherm worked with the CDC and FDA to revise the operating manual and reduce risk to patients, and the 2000i was reintroduced on 1 February 2007. [3]

Related Research Articles

Heliox is a breathing gas mixture of helium (He) and oxygen (O2). It is used as a medical treatment for patients with difficulty breathing because this mixture generates less resistance than atmospheric air when passing through the airways of the lungs, and thus requires less effort by a patient to breathe in and out of the lungs. It is also used as a breathing gas diluent for deep ambient pressure diving as it is not narcotic at high pressure, and for its low work of breathing.

<span class="mw-page-title-main">Respiratory failure</span> Inadequate gas exchange by the respiratory system

Respiratory failure results from inadequate gas exchange by the respiratory system, meaning that the arterial oxygen, carbon dioxide, or both cannot be kept at normal levels. A drop in the oxygen carried in the blood is known as hypoxemia; a rise in arterial carbon dioxide levels is called hypercapnia. Respiratory failure is classified as either Type 1 or Type 2, based on whether there is a high carbon dioxide level, and can be acute or chronic. In clinical trials, the definition of respiratory failure usually includes increased respiratory rate, abnormal blood gases, and evidence of increased work of breathing. Respiratory failure causes an altered mental status due to ischemia in the brain.

<span class="mw-page-title-main">Ventilator</span> Device that provides mechanical ventilation to the lungs

A ventilator is a type of breathing apparatus, a class of medical technology that provides mechanical ventilation by moving breathable air into and out of the lungs, to deliver breaths to a patient who is physically unable to breathe, or breathing insufficiently. Ventilators may be computerized microprocessor-controlled machines, but patients can also be ventilated with a simple, hand-operated bag valve mask. Ventilators are chiefly used in intensive-care medicine, home care, and emergency medicine and in anesthesiology.

<span class="mw-page-title-main">Positive airway pressure</span> Mechanical ventilation in which airway pressure is always above atmospheric pressure

Positive airway pressure (PAP) is a mode of respiratory ventilation used in the treatment of sleep apnea. PAP ventilation is also commonly used for those who are critically ill in hospital with respiratory failure, in newborn infants (neonates), and for the prevention and treatment of atelectasis in patients with difficulty taking deep breaths. In these patients, PAP ventilation can prevent the need for tracheal intubation, or allow earlier extubation. Sometimes patients with neuromuscular diseases use this variety of ventilation as well. CPAP is an acronym for "continuous positive airway pressure", which was developed by Dr. George Gregory and colleagues in the neonatal intensive care unit at the University of California, San Francisco. A variation of the PAP system was developed by Professor Colin Sullivan at Royal Prince Alfred Hospital in Sydney, Australia, in 1981.

<span class="mw-page-title-main">Oxygen therapy</span> Use of oxygen as a medical treatment

Oxygen therapy, also referred to as supplemental oxygen, is the use of oxygen as medical treatment. Supplemental oxygen can also refer to the use of oxygen enriched air at altitude. Acute indications for therapy include hypoxemia, carbon monoxide toxicity and cluster headache. It may also be prophylactically given to maintain blood oxygen levels during the induction of anesthesia. Oxygen therapy is often useful in chronic hypoxemia caused by conditions such as severe COPD or cystic fibrosis. Oxygen can be delivered via nasal cannula, face mask, or endotracheal intubation at normal atmospheric pressure, or in a hyperbaric chamber. It can also be given through bypassing the airway, such as in ECMO therapy.

<span class="mw-page-title-main">Nebulizer</span> Drug delivery device

In medicine, a nebulizer or nebuliser is a drug delivery device used to administer medication in the form of a mist inhaled into the lungs. Nebulizers are commonly used for the treatment of asthma, cystic fibrosis, COPD and other respiratory diseases or disorders. They use oxygen, compressed air or ultrasonic power to break up solutions and suspensions into small aerosol droplets that are inhaled from the mouthpiece of the device. An aerosol is a mixture of gas and solid or liquid particles.

<span class="mw-page-title-main">Nasal cannula</span> Medical device to deliver supplemental oxygen

The nasal cannula (NC) is a device used to deliver supplemental oxygen or increased airflow to a patient or person in need of respiratory help. This device consists of a lightweight tube which on one end splits into two prongs which are placed in the nostrils curving toward the sinuses behind the nose, and from which a mixture of air and oxygen flows. The other end of the tube is connected to an oxygen supply such as a portable oxygen generator, or a wall connection in a hospital via a flowmeter. The cannula is generally attached to the patient by way of the tube hooking around the patient's ears or by an elastic headband, and the prongs curve toward the paranasal sinuses. The earliest, and most widely used form of adult nasal cannula carries 1–3 litres of oxygen per minute.

An oxygen concentrator is a device that concentrates the oxygen from a gas supply by selectively removing nitrogen to supply an oxygen-enriched product gas stream. They are used industrially, to provide supplemental oxygen at high altitudes, and as medical devices for oxygen therapy.

Iduronidase, sold as Aldurazyme, is an enzyme with the systematic name glycosaminoglycan α-L-iduronohydrolase. It catalyses the hydrolysis of unsulfated α-L-iduronosidic linkages in dermatan sulfate.

The venturi mask, also known as an air-entrainment mask, is a medical device to deliver a known oxygen concentration to patients on controlled oxygen therapy. The mask was invented by Moran Campbell at McMaster University Medical School as a replacement for intermittent oxygen treatment. Dr. Campbell was fond of quoting John Scott Haldane's description of intermittent oxygen treatment; "bringing a drowning man to the surface – occasionally". By contrast the venturi mask offered a constant supply of oxygen at a much more precise range of concentrations.

<i>Ralstonia</i> Genus of bacteria

Ralstonia is a genus of bacteria, previously included in the genus Pseudomonas. It is named after the American bacteriologist Ericka Ralston. Ericka Ralston was born Ericka Barrett in 1944 in Saratoga, California, and died in 2015 in Sebastopol, California. While in graduate school at the University of California at Berkeley, she identified 20 strains of Pseudomonas which formed a phenotypical homologous group, and named them Pseudomonas pickettii, after M.J. Pickett in the Department of Bacteriology at the University of California at Los Angeles, from whom she had received the strains. Later, P. pickettii was transferred to the new genus Ralstonia, along with several other species. She continued her research into bacterial pathogenesis under the name of Ericka Barrett while a professor of microbiology at the University of California at Davis from 1977 until her retirement in 1996.

<i>Ralstonia mannitolilytica</i> Species of bacterium

Ralstonia mannitolilytica is a Gram-negative soil bacterium. Pseudomonas thomasii and Ralstonia pickettii biovar 3/thomasii are synonyms.

Puritan Bennett has been a provider of respiratory products since 1913 originally as a medical gas supplier. In addition to critical care ventilation, Puritan Bennett provided medical devices for patients outside of the acute care environment. Its products included portable ventilation, oxygen therapy systems, sleep diagnostic and sleep therapy equipment, spirometry and other respiratory care products.

Respiratory gas humidification is a method of artificially conditioning respiratory gas for the patient during therapy, and involves humidification, warming, and occasionally filtration of the gas being delivered. If these three measures are not performed to compensate for the natural conditioning of air by the respiratory system, lung infections and lung tissue damage may occur. This is particularly problematic in high gas-flow therapies such as [mechanical ventilation], in patient populations with highly sensitive respiratory tracts, or among those requiring ventilation for longer periods of time. The two methods currently available for this purpose are active or passive respiratory gas humidification.

<span class="mw-page-title-main">Portable oxygen concentrator</span> Device used to provide oxygen therapy

A portable oxygen concentrator (POC) is a device used to provide oxygen therapy to people that require greater oxygen concentrations than the levels of ambient air. It is similar to a home oxygen concentrator (OC), but is smaller in size and more mobile. They are small enough to carry and many are now FAA-approved for use on airplanes.

Fisher & Paykel Healthcare Corporation Limited (FPH) is a manufacturer, designer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. Based in New Zealand, their products and systems are sold in around 120 countries worldwide. FPH is primarily an exporting company, with just 1 percent of revenue coming from New Zealand sales.

<span class="mw-page-title-main">Heated humidified high-flow therapy</span> Respiratory support method

Heated humidified high-flow therapy, often simply called high flow therapy, is a type of respiratory support that delivers a flow of medical gas to a patient of up to 60 liters per minute and 100% oxygen through a large bore or high flow nasal cannula. Primarily studied in neonates, it has also been found effective in some adults to treat hypoxemia and work of breathing issues. The key components of it are a gas blender, heated humidifier, heated circuit, and cannula.

Medical gas therapy is a treatment involving the administration of various gases. It has been used in medicine since the use of oxygen therapy. Many other gases, collectively known as factitious airs, were explored for medicinal value in the late eighteenth century.

<span class="mw-page-title-main">New England Compounding Center meningitis outbreak</span> Fungal meningitis outbreak in the United States

A New England Compounding Center meningitis outbreak that began in September 2012 sickened 798 individuals and resulted in the deaths of more than 100 people. In September 2012, the Centers for Disease Control and Prevention, in collaboration with state and local health departments and the Food and Drug Administration (FDA), began investigating a multistate outbreak of fungal meningitis and other infections among patients who had received contaminated steroid injections from the New England Compounding Center (NECC) in Framingham, Massachusetts. The NECC was classified as a compounding pharmacy. The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs.

<span class="mw-page-title-main">Glossary of breathing apparatus terminology</span> Definitions of technical terms used in connection with breathing apparatus

A breathing apparatus or breathing set is equipment which allows a person to breathe in a hostile environment where breathing would otherwise be impossible, difficult, harmful, or hazardous, or assists a person to breathe. A respirator, medical ventilator, or resuscitator may also be considered to be breathing apparatus. Equipment that supplies or recycles breathing gas other than ambient air in a space used by several people is usually referred to as being part of a life-support system, and a life-support system for one person may include breathing apparatus, when the breathing gas is specifically supplied to the user rather than to the enclosure in which the user is the occupant.

References

  1. Jhung, M. A.; Sunenshine, R. H.; Noble-Wang, J.; et al. (1 June 2007). "A National Outbreak of Ralstonia mannitolilytica Associated With Use of a Contaminated Oxygen-Delivery Device Among Pediatric Patients". Pediatrics. 119 (6): 1061–1068. doi:10.1542/peds.2006-3739. PMID   17545371. S2CID   23305295 . Retrieved 28 July 2015.
  2. "Vapotherm ISSUES URGENT NATIONWIDE RECALL OF All Vapotherm 2000i Respiratory Gas Humidification Devices". Food and Drug Administration. 24 January 2006. Retrieved 28 July 2015.
  3. "FDA Public Health Notification: Precautions in Using the Reintroduced Vapotherm®> 2000i [Respiratory Gas Humidifier] System". Food and Drug Administration. Retrieved 28 July 2015.